TelyRx Holdings Inc.
TELY.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 68.72M | 55.39M | 42.92M | 33.30M | 23.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.72M | 55.39M | 42.92M | 33.30M | 23.84M |
| Cost of Revenue | 28.81M | 23.41M | 18.16M | 16.23M | 11.87M |
| Gross Profit | 39.91M | 31.98M | 24.76M | 17.07M | 11.97M |
| SG&A Expenses | 51.13M | 38.99M | 28.91M | 19.04M | 13.30M |
| Depreciation & Amortization | 1.11M | 976.00K | 860.00K | 618.00K | 516.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.80M | 63.12M | 47.69M | 36.03M | 25.68M |
| Operating Income | -12.09M | -7.74M | -4.76M | -2.73M | -1.84M |
| Income Before Tax | -13.29M | -10.05M | -5.41M | 2.85M | -2.44M |
| Income Tax Expenses | 18.00K | 18.00K | 18.00K | -- | -- |
| Earnings from Continuing Operations | -13.30 | -10.06 | -5.43 | 2.85 | -2.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -6.07M | -6.69M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.30M | -10.06M | -5.43M | -3.22M | -9.13M |
| EBIT | -12.09M | -7.74M | -4.76M | -2.73M | -1.84M |
| EBITDA | -11.95M | -7.48M | -4.41M | -2.40M | -1.49M |
| EPS Basic | -0.90 | -0.92 | -0.51 | -0.31 | -0.93 |
| Normalized Basic EPS | -0.44 | -0.45 | -0.32 | -0.19 | -0.15 |
| EPS Diluted | -0.90 | -0.92 | -0.51 | -0.91 | -1.53 |
| Normalized Diluted EPS | -0.44 | -0.45 | -0.32 | -0.19 | -0.15 |
| Average Basic Shares Outstanding | 81.50M | 43.33M | 42.75M | 42.00M | 41.02M |
| Average Diluted Shares Outstanding | 81.50M | 43.33M | 42.75M | 42.00M | 41.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |